Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Fler filtreringsmöjligheter
  1. 2017
  2. Development of a targeted Drug Delivery System for treatment of Pancreatic Ductal Adenocarcinom

    Urey, C., 2017, Lund: Lund University: Faculty of Medicine. 70 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)